Innovative Technology MetriTrack’s FDA-cleared Breast Volume Navigator G-2000 system offers standardized, high-quality breast ultrasound exams with real-time remote expert support, creating opportunities to serve remote clinics, international markets, and healthcare providers seeking telemedicine capabilities.

Growing Partnerships Recent collaborations with mammography education providers and imaging companies demonstrate a strategic focus on expanding market reach, training, and integration, which presents avenues for engaging hospital networks, imaging centers, and educational institutions for product adoption.

Funding & Development With initial seed funding of 1.5 million dollars and a focus on R&D, the company is positioned to accelerate product enhancements and new deployment, creating opportunities for investors, OEM partnerships, and regional distributors to enter the early adopter segment.

Market Validation Getting FDA clearance validates the system’s safety and effectiveness, making it an attractive solution for healthcare providers aiming for regulatory compliance and improved patient outcomes, especially in markets prioritizing cancer screening and early diagnosis.

Addressing Unmet Needs By improving access to breast ultrasound exams and reducing repeat procedures, MetriTrack addresses pain points in breast cancer detection, offering sales prospects with hospitals, clinics, and health systems looking to enhance diagnostic accuracy and patient care efficiency.